These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31744356)

  • 61. Risk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa.
    Ogawa K; Jwa SC; Morisaki N; Sago H
    Arch Gynecol Obstet; 2022 Mar; 305(3):607-615. PubMed ID: 34448037
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical Risk Factors for Placenta Accreta or Placenta Percreta: A Case-Control Study.
    Noël I; Ghesquiere L; Guerby P; Maheux-Lacroix S; Bujold E; Moretti F
    J Obstet Gynaecol Can; 2024 Apr; 46(4):102294. PubMed ID: 37993101
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prediction of clinical outcomes in women with placenta accreta spectrum using machine learning models: an international multicenter study.
    Shazly SA; Hortu I; Shih JC; Melekoglu R; Fan S; Ahmed FUA; Karaman E; Fatkullin I; Pinto PV; Irianti S; Tochie JN; Abdelbadie AS; Ergenoglu AM; Yeniel AO; Sagol S; Itil IM; Kang J; Huang KY; Yilmaz E; Liang Y; Aziz H; Akhter T; Ambreen A; Ateş Ç; Karaman Y; Khasanov A; Larisa F; Akhmadeev N; Vatanina A; Machado AP; Montenegro N; Effendi JS; Suardi D; Pramatirta AY; Aziz MA; Siddiq A; Ofakem I; Dohbit JS; Fahmy MS; Anan MA;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6644-6653. PubMed ID: 34233555
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of low extra-abdominal aortic block in cesarean section for placenta accreta spectrum disorders and its effect on the expression of MDA and SOD.
    Li R; Somasodiran M; Sun T; Chen C; Long M; Xu D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1129-1135. PubMed ID: 36097781
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An obstetric-specific surgical Apgar score predicts maternal morbidity from cesarean hysterectomy for placenta accreta spectrum.
    Munoz JL; Curbelo J; Ramsey PS
    Int J Gynaecol Obstet; 2024 Mar; 164(3):912-917. PubMed ID: 37668180
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Staged treatment of placenta accreta spectrum: A combined surgical and radiological approach.
    West S; Martin A; Copping R; Gard G; Maher R; Seeho S
    Aust N Z J Obstet Gynaecol; 2023 Jun; 63(3):372-377. PubMed ID: 36695433
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy.
    Gatta LA; Weber JM; Gilner JB; Lee PS; Grotegut CA; Herbert KA; Bashir M; Pieper CF; Ronald J; Pabon-Ramos W; Habib AS; Strickland KC; Secord AA; James AH
    Am J Perinatol; 2022 Oct; 29(14):1503-1513. PubMed ID: 35973741
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk factors of massive blood transfusion (MTP) in cesarean hysterectomy for placenta accreta spectrum.
    Munoz JL; Ramsey PS; Greebon LJ; Salazar E; McCann GA; Byrne JJ
    Eur J Obstet Gynecol Reprod Biol; 2024 Feb; 293():32-35. PubMed ID: 38100939
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Criteria for placenta accreta spectrum in the International Federation of Gynaecology and Obstetrics classification, and topographic invasion area are associated with massive hemorrhage in patients with placenta previa.
    Ishibashi H; Miyamoto M; Iwahashi H; Matsuura H; Kakimoto S; Sakamoto T; Hada T; Takano M
    Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1019-1025. PubMed ID: 33715171
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Internal Iliac Artery Balloon Tamponade in Placenta Accreta: Outcomes From the Largest Tertiary Accreta Referral Centre in British Columbia.
    McGinnis JM; Simula NK; Joseph KS; Ubhi JS
    J Obstet Gynaecol Can; 2019 Apr; 41(4):466-472. PubMed ID: 30885297
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Informing the Spectrum of Approaches: Institutional Review of Placenta Accreta Spectrum Disorders Management.
    Bloomfield V; Rogers S; Scattolon S; Morais M; Leyland N
    J Obstet Gynaecol Can; 2022 Apr; 44(4):365-371. PubMed ID: 34740850
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Intrauterine balloon tamponade combined with temporary abdominal aortic balloon occlusion in the management of women with placenta accreta spectrum:a randomized controlled trial].
    Dai YM; Wei J; Wang ZQ; Zhang XB; Cheng L; Gu N; Hu YL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jul; 55(7):450-456. PubMed ID: 32842248
    [No Abstract]   [Full Text] [Related]  

  • 73. MRI of the Placenta Accreta Spectrum (PAS) Disorder: Radiomics Analysis Correlates With Surgical and Pathological Outcome.
    Do QN; Lewis MA; Xi Y; Madhuranthakam AJ; Happe SK; Dashe JS; Lenkinski RE; Khan A; Twickler DM
    J Magn Reson Imaging; 2020 Mar; 51(3):936-946. PubMed ID: 31397528
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The application of prophylactic balloon occlusion of the internal iliac artery for the treatment of placenta accreta spectrum with placenta previa: a retrospective case-control study.
    Peng Y; Jiang L; Peng C; Wu D; Chen L
    BMC Pregnancy Childbirth; 2020 Jun; 20(1):349. PubMed ID: 32513127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urinary tract injuries during surgery for placenta accreta spectrum disorders.
    Giuseppe C; Salvatore P; Federica C; Francesco L; Francesco D; Alessandro L; Gloria C
    Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():93-96. PubMed ID: 37300983
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Placenta accreta spectrum into the parametrium, morbidity differences between upper and lower location.
    Palacios-Jaraquemada JM; Nieto-Calvache Á; Aryananda RA; Basanta N
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2183764. PubMed ID: 36966802
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A 5-year experience on perinatal outcome of placenta accreta spectrum disorder managed by cesarean hysterectomy in southern Iranian women.
    Kasraeian M; Hashemi A; Hessami K; Alamdarloo SM; Vahdani R; Vafaei H; Najib FS; Shiravani Z; Razavi B; Homayoon N; Nayebi M; Bazrafshan K; Jahromi MA
    BMC Womens Health; 2021 Jun; 21(1):243. PubMed ID: 34130685
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical profiles of placenta accreta spectrum: the PACCRETA population-based study.
    Kayem G; Seco A; Beucher G; Dupont C; Branger B; Crenn Hebert C; Huissoud C; Fresson J; Winer N; Langer B; Rozenberg P; Morel O; Bonnet MP; Perrotin F; Azria E; Carbillon L; Chiesa C; Raynal P; Rudigoz RC; Dreyfus M; Vendittelli F; Patrier S; Deneux-Tharaux C; Sentilhes L
    BJOG; 2021 Sep; 128(10):1646-1655. PubMed ID: 33393174
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Retrospective analysis of obstetric and anesthetic management of patients with placenta accreta spectrum disorders.
    Riveros-Perez E; Wood C
    Int J Gynaecol Obstet; 2018 Mar; 140(3):370-374. PubMed ID: 29080306
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regional multidisciplinary team approach to the management of placenta accreta spectrum disorder.
    Yao R; Nguyen HY; Hong L; Karagoyzyan D; Burruss S; Brar H; Staton M; Martin C; Balli K; Ioffe Y
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2190840. PubMed ID: 36927241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.